Military families gain pharmacy choice; PBMs lose hidden-fee leverage

What it does

This bill amends the TRICARE military pharmacy program to give beneficiaries more choice in how they receive maintenance medications starting October 1, 2026, and requires the Department of Defense to ensure retail pharmacies are reimbursed fairly—at least their actual acquisition cost plus a professional dispensing fee—while prohibiting hidden fees. It also mandates annual audits by the Comptroller General to verify reimbursement rates and pharmacy network adequacy.

Why we flagged it

The bill's operative mechanism is to expand beneficiary choice in medication delivery and impose transparent, cost-based reimbursement standards on pharmacy benefit managers administering TRICARE. It is fundamentally a healthcare access and fairness measure, not a deregulation or subsidy.

What the text implies

• Reimbursement floor tied to Medicare/Medicaid rates may increase TRICARE program costs if retail pharmacy margins were previously suppressed below those benchmarks.
• Prohibition on hidden fees and retroactive adjustments removes a revenue stream for the PBM contractor, potentially affecting contract profitability and future bidding.
• Annual Comptroller General audits create ongoing transparency and accountability, but also impose administrative burden on the contractor and DoD.
• Beneficiary election right (Oct 2026) may fragment the pharmacy network if beneficiaries concentrate in lower-cost channels, affecting rural/underserved pharmacy viability despite the bill's stated concern for geographic access.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

Military beneficiaries and their families gain expanded choice in medication delivery and assurance of pharmacy network stability through transparent reimbursement standards. Retail pharmacies gain protection against hidden fees and reimbursement below cost, which supports network viability and continuity of care—a direct public benefit for a defined but significant population (military families).

Who stands to gain

• retail pharmacies (reimbursement floor protection)
• military beneficiaries (expanded choice, network stability)

Named in the bill

Department of Defense, TRICARE program, Comptroller General of the United States, Centers for Medicare and Medicaid Services, pharmacy benefit manager (PBM) contractor, retail pharmacies, military beneficiaries, House Committee on Armed Services, Senate Committee on Armed Services

Where it stands

18 cosponsors: 11 Republicans, 7 Democrats.

• Dec 3, 2025 — Introduced · Congress.gov: “Introduced in House”
• Dec 3, 2025 — Referred to House Committee on Armed Services · Congress.gov: “Referred to the House Committee on Armed Services”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

5 lobbying clients named this bill on 5 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $3,082,137 in lobbying spend. A filing names 26 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 78% of bills with at least one filing.

Jennifer Kiggans, the sponsor, reported $1,294,089 in PAC receipts in the 2026 cycle. $10,500 of that came from 2 PACs tied to these lobbying clients.

• Walmart Inc — $2,060,000 on 1 filing
• Kroger Co — $350,000 on 1 filing
• National Association of Chain Drug Stores — $290,000 on 1 filing
• National Community Pharmacists Association — $270,000 on 1 filing
• Paralyzed Veterans of America — $112,137 on 1 filing

Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.